Journal of Antimicrobial Chemotherapy (2000) 45, 457-466
© 2000 The British Society for Antimicrobial Chemotherapy
Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997–1998
MRL Pharmaceutical Services, a Herndon, VA; b Den Brielstraat 11, 3554 XD, Utrecht, The Netherlands; and c Brentwood, TN, USA
A multicentre, collaborative study was performed in Asia and Europe during the winter of 1997–1998 to determine the in vitro activity of selected antimicrobial agents against common respiratory pathogens. Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolates were collected from 48 sites in China, France, Germany, Italy, Japan, Spain and the UK and tested in a central laboratory in the USA. Broth microdilution MICs were determined for ß-lactams (penicillin, amoxycillin/clavulanate, cefuroxime, ceftriaxone), macrolides (azithromycin, clarithromycin), sulphonamides (co-trimoxazole), glycopeptides (vancomycin) and fluoroquinolones (levofloxacin). The percentage of isolates susceptible to each antimicrobial class varied substantially by country. Penicillin susceptibility amongst pneumococci ranged from 34% in France and Spain to 92% in Germany, and macrolide susceptibility varied between 26% in China and 91% in the UK. In most countries ß-lactam, macrolide and cotrimoxazole resistance was more prevalent amongst penicillin-intermediate and -resistant S. pneumoniae isolates. However, little or no resistance was detected to levofloxacin (0.3% intermediate and resistant) or vancomycin (0% intermediate and resistant). For H. influenzae the prevalence of ß-lactamase production varied from 6% in China and Germany to 32% in Spain, and for M. catarrhalis, from 79% in Germany to 98% in Japan. With the exception of ampicillin, ß-lactamase production had a minimal effect on ß-lactam activity against H. influenzae or M. catarrhalis. Our findings demonstrate that antimicrobial resistance profiles of common respiratory isolates differ dramatically between countries in Asia and Europe.
* Corresponding author. Tel: +31-30-265-1794; Fax: +31-30-265-1784; E-mail: mjones{at}thetsn.com
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Karpanoja, S. T. Nyberg, M. Bergman, T. Voipio, P. Paakkari, P. Huovinen, H. Sarkkinen, and and the Finnish Study Group for Antimicrobial Resi Connection between Trimethoprim-Sulfamethoxazole Use and Resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Antimicrob. Agents Chemother., July 1, 2008; 52(7): 2480 - 2485. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Y. Fukushima, K. Yanagihara, Y. Hirakata, K. Sugahara, Y. Morinaga, S. Kohno, and S. Kamihira Rapid Identification of Penicillin and Macrolide Resistance Genes and Simultaneous Quantification of Streptococcus pneumoniae in Purulent Sputum Samples by Use of a Novel Real-Time Multiplex PCR Assay J. Clin. Microbiol., July 1, 2008; 46(7): 2384 - 2388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. G. Zhanel, J. James, S. Derkatch, N. Laing, A. M. Noreddin, and D. J. Hoban Pharmacodynamic activity of garenoxacin against ciprofloxacin-resistant Streptococcus pneumoniae J. Antimicrob. Chemother., July 1, 2006; 58(1): 112 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Fujikawa, M. Chiba, M. Tanaka, and K. Sato In Vitro Antibacterial Activity of DX-619, a Novel Des-Fluoro(6) Quinolone Antimicrob. Agents Chemother., July 1, 2005; 49(7): 3040 - 3045. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D J Farrell, S G Jenkins, and R R Reinert Global distribution of Streptococcus pneumoniae serotypes isolated from paediatric patients during 1999-2000 and the in vitro efficacy of telithromycin and comparators J. Med. Microbiol., November 1, 2004; 53(11): 1109 - 1117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W-S Lim Identifying failure of empirical treatment for pneumonia: vigilance and common sense Thorax, November 1, 2004; 59(11): 918 - 919. [Full Text] [PDF]
|
|
|
|
|
|
D. J. Farrell, I. Morrissey, S. Bakker, L. Morris, S. Buckridge, and D. Felmingham Molecular Epidemiology of Multiresistant Streptococcus pneumoniae with Both erm(B)- and mef(A)-Mediated Macrolide Resistance J. Clin. Microbiol., February 1, 2004; 42(2): 764 - 768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Otani, M. Tanaka, E. Ito, Y. Kurosaka, Y. Murakami, K. Onodera, T. Akasaka, and K. Sato In Vitro and In Vivo Antibacterial Activities of DK-507k, a Novel Fluoroquinolone Antimicrob. Agents Chemother., December 1, 2003; 47(12): 3750 - 3759. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J Schentag, A. K Meagher, and A. Forrest Fluoroquinolone AUIC Break Points and the Link to Bacterial Killing Rates: Part 1: In Vitro and Animal Models Ann. Pharmacother., September 1, 2003; 37(9): 1287 - 1298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Davies, R. Goldschmidt, S. Pfleger, M. Loeloff, K. Bush, D. F. Sahm, and A. Evangelista Cross-resistance, relatedness and allele analysis of fluoroquinolone-resistant US clinical isolates of Streptococcus pneumoniae (1998-2000) J. Antimicrob. Chemother., August 1, 2003; 52(2): 168 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Singer, I. Harding, M. R. Jacobs, and D. H. Jaffe Impact of antimicrobial resistance on health outcomes in the out-patient treatment of adult community-acquired pneumonia: a probability model J. Antimicrob. Chemother., May 1, 2003; 51(5): 1269 - 1282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Morrissey, D. J. Farrell, S. Bakker, S. Buckridge, and D. Felmingham Molecular Characterization and Antimicrobial Susceptibility of Fluoroquinolone-Resistant or -Susceptible Streptococcus pneumoniae from Hong Kong Antimicrob. Agents Chemother., April 1, 2003; 47(4): 1433 - 1435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. A. Critchley, D. C. Draghi, D. F. Sahm, C. Thornsberry, M. E. Jones, and J. A. Karlowsky Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000-2001 J. Antimicrob. Chemother., March 1, 2003; 51(3): 639 - 649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Jones, J. A. Karlowsky, R. Blosser-Middleton, I. Critchley, C. Thornsberry, and D. F. Sahm Relationship between Antibiotic Resistance in Streptococcus pneumoniae and That in Haemophilus influenzae: Evidence for Common Selective Pressure Antimicrob. Agents Chemother., September 1, 2002; 46(9): 3106 - 3107. [Full Text] [PDF]
|
|
|
|
|
|
V. I. Enne, A. King, D. M. Livermore, and L. M. C. Hall Sulfonamide Resistance in Haemophilus influenzae Mediated by Acquisition of sul2 or a Short Insertion in Chromosomal folP Antimicrob. Agents Chemother., June 1, 2002; 46(6): 1934 - 1939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.-J. Schmitz, A. Beeck, M. Perdikouli, M. Boos, S. Mayer, S. Scheuring, K. Kohrer, J. Verhoef, and A. C. Fluit Production of BRO {beta}-Lactamases and Resistance to Complement in European Moraxella catarrhalis Isolates J. Clin. Microbiol., April 1, 2002; 40(4): 1546 - 1548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Parra, C. Ponte, C. Cenjor, G. Garcia-Calvo, M. J. Gimenez, L. Aguilar, and F. Soriano Optimal Dose of Amoxicillin in Treatment of Otitis Media Caused by a Penicillin-Resistant Pneumococcus Strain in the Gerbil Model Antimicrob. Agents Chemother., March 1, 2002; 46(3): 859 - 862. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-I. Kadota, Y. Ishimatsu, T. Iwashita, Y. Matsubara, K. Tomono, M. Tateno, R. Ishihara, C. Muller-Serieys, and S. Kohno Intrapulmonary Pharmacokinetics of Telithromycin, a New Ketolide, in Healthy Japanese Volunteers Antimicrob. Agents Chemother., March 1, 2002; 46(3): 917 - 921. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Morris and R. G. Masterton Antibiotic resistance surveillance: action for international studies J. Antimicrob. Chemother., January 1, 2002; 49(1): 7 - 10. [Full Text] [PDF]
|
|
|
|
|
|
R. R. Reinert, A. Al-Lahham, M. Lemperle, C. Tenholte, C. Briefs, S. Haupts, H. H. Gerards, and R. Lutticken Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany J. Antimicrob. Chemother., January 1, 2002; 49(1): 61 - 68. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Glatz, D. Szabo, G. Szabo, D. Boriszova, and F. Rozgonyi Emergence of extremely high penicillin and cefotaxime resistance and high-level levofloxacin resistance in clinical isolates of Streptococcus pneumoniae in Hungary J. Antimicrob. Chemother., November 1, 2001; 48(5): 731 - 734. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Marco, J. Garcia-de-Lomas, C. Garcia-Rey, E. Bouza, L. Aguilar, C. Fernandez-Mazarrasa, and The Spanish Surveillance Group for Respiratory Pat Antimicrobial Susceptibilities of 1,730 Haemophilus influenzae Respiratory Tract Isolates in Spain in 1998-1999 Antimicrob. Agents Chemother., November 1, 2001; 45(11): 3226 - 3228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Thornsberry, J. A. Karlowsky, D. F. Sahm, J. H. Jorgensen, L. M. Weigel, J. M. Swenson, C. G. Whitney, F. C. Tenover, and M. J. Ferraro Levofloxacin-Resistant Streptococcus pneumoniae: Second Look Antimicrob. Agents Chemother., July 1, 2001; 45(7): 2183 - 2184. [Full Text] [PDF]
|
|
|
|
|
|
D. F. Sahm, J. A. Karlowsky, L. J. Kelly, I. A. Critchley, M. E. Jones, C. Thornsberry, Y. Mauriz, and J. Kahn Need for Annual Surveillance of Antimicrobial Resistance in Streptococcus pneumoniae in the United States: 2-Year Longitudinal Analysis Antimicrob. Agents Chemother., April 1, 2001; 45(4): 1037 - 1042. [Abstract] [Full Text]
|
|
|
|
|
|
F. Fitoussi, C. Doit, P. Geslin, N. Brahimi, and E. Bingen Mechanisms of Macrolide Resistance in Clinical Pneumococcal Isolates in France Antimicrob. Agents Chemother., February 1, 2001; 45(2): 636 - 638. [Abstract] [Full Text]
|
|
|
|
|
|
M. E. Jones, A. M. Staples, I. Critchley, C. Thornsberry, P. Heinze, H. D. Engler, and D. F. Sahm Benchmarking the In Vitro Activities of Moxifloxacin and Comparator Agents against Recent Respiratory Isolates from 377 Medical Centers throughout the United States Antimicrob. Agents Chemother., October 1, 2000; 44(10): 2645 - 2652. [Abstract] [Full Text]
|
|